Nivolumab/Relatlimab-rmbw: A Novel Dual Combination Therapy to Treat Adult and Pediatric Patients With Unresectable or Metastatic Melanoma.

Thomas, Baily; Burns, Madison; Pervanas, Helen; Ciurescu, Daniel; Dima, Lorena

Thomas, Baily; Burns, Madison; Pervanas, Helen; Ciurescu, Daniel; Dima, Lorena.

Affiliation

Thomas B; Sanofi Specialty Care, Cambridge, MA.
Burns M; Sanofi Specialty Care, Cambridge, MA.
Pervanas H; Massachusetts College of Pharmacy and Health Sciences University, Manchester, NH.
Ciurescu D; Faculty of Medicine, Department of Medical and Surgical Specialties, Transilvania University of Brasov, Romania; and.
Dima L; Faculty of Medicine, Department of Fundamental Disciplines and Clinical Prevention, Transilvania University of Brasov, Brasov, Romania.

Am J Ther ; 30(6): e526-e534, 2023.

Article de En | MEDLINE | ID: mdl-37921680

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Nivolumab / Mélanome Limites: Adult / Child / Humans Langue: En Journal: Am J Ther Sujet du journal: TERAPEUTICA Année: 2023 Type de document: Article Pays d'affiliation: Maroc

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google